Titan Pharmaceuticals Inc
TTNPDelisted Oct 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000910267
Titan Pharmaceuticals Inc was delisted on Oct 2, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 18 institutions reported holding it in 13F filings for Q3 2025, worth $107.1K in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Titan Pharmaceuticals Inc changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 24 | 23 | −1 |
| Shares | 332.6K | 581.2K | +248.7K (+74.8%) |
| Value | $988.1K | $1.51M | +$523.0K (+52.9%) |
New holders (5)
Institutions that held Titan Pharmaceuticals Inc at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 33,309 | $87.0K | 0.01% |
| Advisory Services Network, LLC | 9,000 | $23.0K | 0.00% |
| FMR LLC | 1 | $0 | 0.00% |
| Sargent Bickham Lagudis LLC | 2 | $0 | 0.00% |
| Pacifica Partners Inc. | 6 | $0 | 0.00% |
Sold out (6)
Institutions that held Titan Pharmaceuticals Inc at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Gsa Capital Partners LLP | 39,820 | $119.0K |
| Credit Suisse AG | 23,200 | $69.0K |
| Millennium Management LLC | 16,882 | $50.0K |
| Simplex Trading, LLC | 3,043 | $9.00K |
| Royal Bank of Canada | 17 | $0 |
| Sowell Financial Services LLC | 19 | $0 |